Therefore, we tested the genetic inhibition of HuR using HuR-specific siRNA containing nanoparticles (HuR-NP) in two melanoma cell lines differing in their B-RAF status (MeWo, B-RAFwt, and A375, B-RAFV600E). The gene discussed is ELAVL1; the disease is melanoma.